Generic Tiering Requirement, Enhanced Oversight On Chronic Meds Proposed For Marketplace Plans
Executive Summary
Commercial health insurance plans governed by the Affordable Care Act would need to modify their formularies for 2024 with policies to avoid discriminatory coverage of four ‘chronic ... high-cost medical conditions’ as well as overpayment for generics, according to CMS proposals.
You may also be interested in...
CMS ‘Safe Harbor’ For Use Of Copay Accumulators In Private Insurance Challenged In Court
Patient groups ‘left with no choice’ but to challenge federal regulation allowing commercial payers to bar manufacturer assistance with drug costs from being counted toward deductibles and out-of-pocket spending caps.
Copay Accumulator-Type Programs Proposed For ACA Exchange Plans
Annual payment rule for individual and group plans governed by Affordable Care Act proposes excluding drug manufacturer-sponsored copay assistance from out-of-pocket caps and seeks comments on use of reference pricing.
FTC Early Findings In PBM Investigation Coming By Mid-Summer, Chair Kahn Says
The agency is also poised to announce another development in its scrutiny of the drug patents listed in the FDA’s Orange Book.